Showing results (291-300 of 678) with videos related to
Sort By:
Pageof 68
Journal of Consulting and Clinical Psychology|January 26, 2011
Effectiveness of partner social support predicts enduring psychological distress after hematopoietic stem cell transplantationChristine Rini, William H Redd, Jane Austin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Phase II study of bendamustine in relapsed and refractory Hodgkin lymphomaAlison J Moskowitz, Paul A Hamlin, Miguel-Angel Perales, et al.British Journal of Haematology|October 4, 2007
Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphomaOwen A O'Connor, Paul A Hamlin, Carol Portlock, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 7, 2022
The Impact of Semiautomatic Segmentation Methods on Metabolic Tumor Volume, Intensity, and Dissemination Radiomics in 18F-FDG PET Scans of Patients with Classical Hodgkin LymphomaJulia Driessen, Gerben J C Zwezerijnen, Heiko Schöder, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2011
Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphomaJohn Gerecitano, Carol Portlock, Paul Hamlin, et al.British Journal of Haematology|September 22, 2016
Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphomaScott D Ramsey, Auayporn Nademanee, Tamas Masszi, et al.Bone Marrow Transplantation|September 20, 2016
Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL studyE Van Den Neste, N Schmitz, N Mounier, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2014
Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphomaParastoo B Dahi, Roni Tamari, Sean M Devlin, et al.Blood|December 21, 2011
Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphomaCraig H Moskowitz, Matt J Matasar, Andrew D Zelenetz, et al.Bone Marrow Transplantation|September 15, 2015
Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL studyE Van Den Neste, N Schmitz, N Mounier, et al.Pageof 68